Business
Mallinckrodt Names Leslie Donato to Board of Directors
Mallinckrodt plc today announced that Leslie Donato has been appointed to the Company's Board of Directors, bringing the board's composition to a total of nine members.
About this update from Cencora, Inc.
[{"type":"text","content":"Appointment of Former Cencora Executive Completes Nine-Member Board","length":67,"tagName":"p","attribs":{}},{"type":"text","content":"DUBLIN, Aug. 4, 2025 /PRNewswire/ -- Mallinckrodt plc today announced that Leslie Donato has been appointed to the Company's Board of Directors, bringing the board's composition to a total of nine members.","length":218,"tagName":"p"},{"type":"image","alt":"Leslie Donato","displaySize":"","headline":null,"caption":"Leslie Donato","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":267,"url":"https://media.zenfs.com/en/prnewswire.com/0da94e4b59c87430fe6d5d26bb374563"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/_E83DXWhx07mD5f_lsUGoA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQ3MTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/0da94e4b59c87430fe6d5d26bb374563","width":400,"height":267}},"href":"https://mma.prnewswire.com/media/2742690/Leslie_Donato_Mallinckrodt_plc.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"An accomplished healthcare industry executive with broad expertise across strategy, corporate development, marketing, commercialization, and product development, Ms. Donato most recently served as Executive Vice President and Chief Strategy Officer of Cencora, Inc., a leading global pharmaceutical solutions organization. While at Cencora, she executed an ambitious M&A and growth strategy, committing over $10 billion in capital and contributing to a 130% increase in Cencora's market capitalization over five years.","length":526,"tagName":"p"},{"type":"text","content":"Her appointment follows Mallinckrodt's announcement on August 1, 2025, that it had completed its merger with Endo, Inc., to create a global, scaled, diversified therapeutics leader. The company's board now consists of four members from each of the legacy companies, and Ms. Donato, who was jointly selected by her fellow board members.","length":343,"tagName":"p"},{"type":"text","content":""We are delighted to welcome Leslie to Mallinckrodt's Board of Directors," said Board Chair Paul Efron. "Her wealth of experience in the healthcare industry will inform the board's strategic discussions and provide valuable insight for setting the direction of the company. We look forward to the contribution that we know Leslie will ...